Jay R. Luly
2014
In 2014, Jay R. Luly earned a total compensation of $2.5M as President and Chief Executive Officer at Enanta Pharmaceuticals, a 53% increase compared to previous year.
Compensation breakdown
Bonus | $262,455 |
---|---|
Option Awards | $1,755,908 |
Salary | $489,382 |
Other | $11,369 |
Total | $2,519,114 |
Luly received $1.8M in option awards, accounting for 70% of the total pay in 2014.
Luly also received $262.5K in bonus, $489.4K in salary and $11.4K in other compensation.
Rankings
In 2014, Jay R. Luly's compensation ranked 3,621st out of 13,032 executives tracked by ExecPay. In other words, Luly earned more than 72.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,621 | 72nd |
Manufacturing | 1,275 | 74th |
Chemicals And Allied Products | 414 | 76th |
Drugs | 320 | 77th |
Pharmaceutical Preparations | 260 | 75th |
Luly's colleagues
We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2014.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019